Date: 30-Aug-2019

USFDA issues warning letter to Lantech Pharma for manufacturing violations at Andhra plant

American health regulator USFDA has pulled up Lantech Pharmaceuticals for violation of current good manufacturing practice norms, including failure to investigate presence of a carcinogen in a solvent, at its Andhra Pradesh-based manufacturing plant.